ATE173476T1 - 1-(4-(imidazol-1-yl)benzoyl>piperidin-derivate als antiarrhythmica - Google Patents

1-(4-(imidazol-1-yl)benzoyl>piperidin-derivate als antiarrhythmica

Info

Publication number
ATE173476T1
ATE173476T1 AT91911396T AT91911396T ATE173476T1 AT E173476 T1 ATE173476 T1 AT E173476T1 AT 91911396 T AT91911396 T AT 91911396T AT 91911396 T AT91911396 T AT 91911396T AT E173476 T1 ATE173476 T1 AT E173476T1
Authority
AT
Austria
Prior art keywords
antiarrhythmics
benzoyl
imidazole
piperidine derivatives
agents
Prior art date
Application number
AT91911396T
Other languages
English (en)
Inventor
You-Ling Chou
Paul William Erhardt
Alfred Arthur Hagedorn
John W Lampe
William Carl Lumma Jr
Thomas Kenneth Morgan
Jay Ross Wiggins
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Application granted granted Critical
Publication of ATE173476T1 publication Critical patent/ATE173476T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
AT91911396T 1990-06-20 1991-06-19 1-(4-(imidazol-1-yl)benzoyl>piperidin-derivate als antiarrhythmica ATE173476T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/540,980 US5189036A (en) 1990-06-20 1990-06-20 Imidazolylbenzoyl substituted heterocycles

Publications (1)

Publication Number Publication Date
ATE173476T1 true ATE173476T1 (de) 1998-12-15

Family

ID=24157703

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91911396T ATE173476T1 (de) 1990-06-20 1991-06-19 1-(4-(imidazol-1-yl)benzoyl>piperidin-derivate als antiarrhythmica

Country Status (6)

Country Link
US (1) US5189036A (de)
EP (1) EP0537201B1 (de)
JP (1) JPH05509303A (de)
AT (1) ATE173476T1 (de)
DE (1) DE69130505D1 (de)
WO (1) WO1991019709A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996019475A1 (en) * 1994-12-22 1996-06-27 Smithkline Beecham Corporation Fibrinogen receptor antagonists
GB2327418A (en) * 1997-07-18 1999-01-27 Rhone Poulenc Agriculture Derivatives of 2-benzoylcyclohexane-1,3-dione
US5977376A (en) * 1997-07-18 1999-11-02 Rhone-Poulenc Agriculture Limited Herbicidal 2-benzoylcyclohexane-1,3-diones and related compounds
US6376514B1 (en) 2000-10-17 2002-04-23 The Procter & Gamble Co. Substituted six-membered heterocyclic compounds useful for treating multidrug resistance and compositions and methods thereof
WO2002068409A1 (en) 2001-02-23 2002-09-06 Merck & Co., Inc. N-substituted nonaryl-heterocyclic nmda/nr2b antagonists
US7259157B2 (en) 2001-04-03 2007-08-21 Merck & Co., Inc. N-substituted nonaryl-heterocyclo amidyl NMDA/NR2B Antagonists
AU2002322720B2 (en) 2001-07-25 2008-11-13 Raptor Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
CN102379684B (zh) 2005-04-28 2014-11-19 普罗透斯数字保健公司 药物信息系统
AR059826A1 (es) * 2006-03-13 2008-04-30 Univ California Inhibidores de urea conformacionalmente restringidos de epoxido hidrolasa soluble
KR20090071598A (ko) 2006-09-18 2009-07-01 랩터 파마슈티컬 인코포레이티드 수용체 결합 단백질(rap)-접합체 투여에 의한 간 질환의 치료
JP2010507587A (ja) * 2006-10-20 2010-03-11 アレテ セラピューティクス, インコーポレイテッド 可溶性エポキシドヒドロラーゼ阻害剤
MX2009004089A (es) * 2006-10-20 2009-07-10 Arete Therapeutics Inc Inhibidores de epoxido hidrolasa soluble.
EP2132176A1 (de) * 2007-03-13 2009-12-16 Arete Therapeutics, Inc. 4-piperidinylharnstoffverbindungen als lösliche epoxidhydrolaseinhibitoren
EP2398500B1 (de) 2009-02-20 2019-03-13 2-BBB Medicines B.V. Arzneiabgabesystem auf glutathion-basis
ES2942923T3 (es) 2009-05-06 2023-06-07 Laboratory Skin Care Inc Composiciones de administración dérmica que comprenden complejos de agente activo-partículas de fosfato de calcio y métodos de uso de las mismas
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4804662A (en) * 1987-05-05 1989-02-14 Schering A.G. Substituted 4-(1H-imidazol-1-yl)benzamides as antiarrhythmic agents
US4851526A (en) * 1987-09-04 1989-07-25 Schering A.G. 1-(4-Substituted phenyl)-1H-imidazoles compounds
US4868194A (en) * 1988-09-23 1989-09-19 Merrell Dow Pharmaceuticals Inc. Imidazole antiarrhythmics

Also Published As

Publication number Publication date
JPH05509303A (ja) 1993-12-22
EP0537201B1 (de) 1998-11-18
US5189036A (en) 1993-02-23
WO1991019709A1 (en) 1991-12-26
DE69130505D1 (de) 1998-12-24
EP0537201A1 (de) 1993-04-21

Similar Documents

Publication Publication Date Title
DE69130505D1 (de) 1-[4-(imidazol-1-yl)benzoyl]piperidin-derivate als antiarrhythmica
DK0563345T3 (da) Nye 4-arylpiperaziner og 4-arylpiperidiner
DE69226953D1 (de) Verwendung von tetrahydrocarbazolderivaten als 5ht1-rezeptor-agonisten
DE69628804D1 (de) Substitutierte heterozyclische Derivate als CRF Antagonisten
DK394589D0 (da) 3-heterocyclyl-2-phenyl-1-(1h-1,2,4-triazol-1-yl)-alkan-2-ol-forbindelser, deres anvendelse til fremstilling af antifungale midler, farmaceutiske praeparater indeholdende forbindelserne og mellemprodukter ved fremstilling af forbindelserne
DE69024281D1 (de) Azole als Pestizide
ES8507541A1 (es) Un procedimiento para la preparacion de 1h-imidazolez y 1h-1,2,4-triazoles.
DK0409435T3 (da) Heteroarylpiperaziner som antipsykotiske midler
DE68928262D1 (de) Derivate von Alkanolaminen als kardiovaskuläre Mittel
NO924598L (no) Fremstilling av substituerte piperidiner
ATE208621T1 (de) Stabilisierung der prostaglandinzusammensetzungen
ATE102191T1 (de) Substituierte 4-(1h-imidazol-1-yl>benzamide als antiarrhythmische mittel.
ITMI913374A0 (it) Nuovi composti tetrametilpiperidinici atti all'impiego come stabilizzanti per materiali organici
DE59200199D1 (de) Fungizide Mischung.
NO900019D0 (no) Piperidiner og fremgangsmaate til fremstilling derav.
ATE116316T1 (de) Antipsychotische 4-(1,2- benzisoazolyl)piperidinderivate.
DK0439265T3 (da) Hidtil ukendte 1,3-dicarbonylforbindelser og anvendelse deraf
DK686088A (da) 2-phenyl-3-(piperazin-1-yl)-1-(1h-1,2,4-triazol-1-yl) propan-2-ol-forbindelser
ITMI931685A0 (it) Nuovi derivati di polialchil-4-piperidinoli atti all'impiego come stabilizzanti per materiali organici
NO20033184D0 (no) Anvendelse av forbindelsen (+)-<alfa>-(2,3-dimetoksyfenyl)-1- [2-(4-fluorfenyl)etyl]-4-piperidinmetanol
DE69211571D1 (de) Zusammensetzungen die 1,1,1,2-tetrafluoroethan enthalten und Verwendung von diesen Zusammensetzungen
FI915056A7 (fi) Substituoidut 1-(alkoksi-iminoalkyyli)imidatsoli-johdannaiset
ATE130162T1 (de) Fungizide wirkstoffkombinationen.
DK151082A (da) Fungicidt middel indeholdende triazolylderivater
ATE74130T1 (de) Pro-drug-derivate vom kardiotonischen agenz 4ethyl-1,3-dihydro-5(4-(2-methyl-1h-imidazol-1-y )-benzoyl>>-2h-imidazol-one.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties